Thomas J. Hoerger

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter by Type

Filter by Year

Filter by Focus Area

Filter by Solution

Filter by Center

Search Results

A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050

Simulation Modeling: Preventing Complications in Chronic Disease

New Study Projects Treatments Needed to Eliminate Hepatitis C Infection in U.S. Regions

In reply to 'The Myth of the Future Burden of CKD in United States'

Loss volatility, bankruptcy, and the demand for reinsurance

Uncertainty, information and resolution of medical malpractice disputes

High-risk individuals' willingness to pay for diabetes risk-reduction programs

Costs and Consequences Associated With Newer Medications for Glycemic Control in Type 2 Diabetes

Inaugural conjoint analysis in health conference

Scaling up Hepatitis C prevention and treatment interventions for achieving elimination in the United States: A rural and urban comparison

AcademyHealth 2016 Annual Research Meeting

Perceived impact of incentives for chronic disease prevention

Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC study

Cost-effectiveness of bariatric surgery for severely obese adults with diabetes

Study Finds a Diabetes Prevention Program Could Save $5.7 Billion in 25 Years

Cost of medical care in Raleigh among the most expensive in nation, survey finds

Impact of the YMCA of the USA diabetes prevention program on Medicare spending and utilization

Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs

The cost-effectiveness of anemia treatment for persons with chronic kidney disease

Estimating state-level health burden of diabetes: Diabetes-attributable fractions for diabetes complications